[Enhancement of vascular level in tumors under angiotensin-induced hypertension]. 1985

K Hori, and M Suzuki, and I Abe, and S Saito

The change in tumor vascular area seems to be one of the important factors influencing drug delivery to tumor tissue. By means of a point-counting method we analyzed changes in the "vascular level", percentage of the vascular area to tissue area, in two tumors; AH272, AH109A, comparatively under angiotensin-induced hypertension. In tumor AH272, the vascular level changed from 27.4% (range; 19.7-34.9%) to 38.5% (range; 28.2-48.1%) when mean arterial blood pressure elevated from 98.3 to 151.7 mmHg. The change coefficient due to angiotensin II was 1.42. The vascular level in AH109A tumor tissue increased from 19.7% (range; 0-48.5%) to 33.9% (range; 8.7-57.6%) with an elevation of mean arterial pressure from 103.5 to 150.8 mmHg. The change coefficient was AH109A in 2.08. In-homogeneity in the vascular level in tumor tissue was more marked in AH109A than in AH272. Moreover, it was revealed in AH 109A that the increase in the vascular level due to angiotensin II was greater in the areas with a lower vascular level. This seems to be caused by the phenomenon that blood flow appearing under angiotensin-induced hypertension in tumor vessels that lacked blood flow at normotension. In conclusion, selective increase in vascular level was seen in both tumors under angiotensin-induced hypertension.

UI MeSH Term Description Entries
D008102 Liver Circulation The circulation of BLOOD through the LIVER. Hepatic Circulation,Circulation, Liver,Circulation, Hepatic
D008114 Liver Neoplasms, Experimental Experimentally induced tumors of the LIVER. Hepatoma, Experimental,Hepatoma, Morris,Hepatoma, Novikoff,Experimental Hepatoma,Experimental Hepatomas,Experimental Liver Neoplasms,Hepatomas, Experimental,Neoplasms, Experimental Liver,Experimental Liver Neoplasm,Liver Neoplasm, Experimental,Morris Hepatoma,Novikoff Hepatoma
D008297 Male Males
D008833 Microcirculation The circulation of the BLOOD through the MICROVASCULAR NETWORK. Microvascular Blood Flow,Microvascular Circulation,Blood Flow, Microvascular,Circulation, Microvascular,Flow, Microvascular Blood,Microvascular Blood Flows,Microvascular Circulations
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

K Hori, and M Suzuki, and I Abe, and S Saito
May 1988, Tsurumi shigaku. Tsurumi University dental journal,
K Hori, and M Suzuki, and I Abe, and S Saito
June 1991, Acta paediatrica Japonica : Overseas edition,
K Hori, and M Suzuki, and I Abe, and S Saito
May 2005, Canadian journal of physiology and pharmacology,
K Hori, and M Suzuki, and I Abe, and S Saito
July 2003, Journal of hypertension,
K Hori, and M Suzuki, and I Abe, and S Saito
January 2022, Frontiers in pharmacology,
K Hori, and M Suzuki, and I Abe, and S Saito
January 1986, Radiation medicine,
K Hori, and M Suzuki, and I Abe, and S Saito
January 1995, Blood pressure. Supplement,
K Hori, and M Suzuki, and I Abe, and S Saito
March 2006, Current opinion in nephrology and hypertension,
K Hori, and M Suzuki, and I Abe, and S Saito
February 2010, Hypertension (Dallas, Tex. : 1979),
Copied contents to your clipboard!